without any signs of liver damage. It may, therefore, be more feasible to restore HBV-specific immunity to mimic the immunological events that occur during acute infection (Fig. 1b).
without any signs of liver damage. It may, therefore, be morefeasible to restore HBV-specific immunity to mimicthe immunological events that occur during acuteinfection (Fig. 1b).